Ventricular fibrillation.
D031841:Aconitum / Q000494:pharmacology; D000200:Action Potentials; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001831:Body Temperature; D002118:Calcium / Q000378:metabolism; D005117:Cardiac Complexes, Premature / Q000503:physiopathology; D002306:Cardiac Volume; D003327:Coronary Disease / Q000503:physiopathology; D004071:Digitalis Glycosides / Q000494:pharmacology; D004558:Electric Stimulation; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology*; D006339:Heart Rate; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008564:Membrane Potentials; D009206:Myocardium / Q000378:metabolism; D010640:Phenothiazines; D011188:Potassium / Q000378:metabolism; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D013610:Tachycardia / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000209:etiology / Q000503:physiopathology*
D014150:Antipsychotic Agents; D004071:Digitalis Glycosides; D010640:Phenothiazines; D011802:Quinidine; D011342:Procainamide; D011188:Potassium; D002118:Calcium